Clinical Trial Update: Kuvan®'s Effect on the Cognition of Children With Phenylketonuria [Phase 4]

View source ↗

Summary

Phase 4 trial assessing Kuvan® (tetrahydrobiopterin) effect on cognition in children with phenylketonuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• KUVAN (Sapropterin dihydrochloride)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonuria | Phase 4 | Status: COMPLETED